Predictors of patients' perceived need for medication to prevent fracture

Medical Care

Volumn 49, Issue 3, 2011, Pages 273-280

  Schousboe, John T ^a,b   Davison, Mark L ^c   Dowd, Bryan ^a   Thiede Call, Kathleen ^a   Johnson, Paul ^d   Kane, Robert L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PARK NICOLLET INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

concerns about medication; fracture risk; medication compliance; perceived need for medication; trust in physician

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BONE DENSITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEEDS ASSESSMENT; PATIENT ATTITUDE; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; SPINE RADIOGRAPHY; VERTEBRA FRACTURE;

AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CROSS-SECTIONAL STUDIES; DIPHOSPHONATES; FEMALE; FRACTURES, BONE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 79951683480     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318202915e     Document Type: Article

References (60)

1. Nguyen ND, Ahlborg HG, Center JR, et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res. 2007;22:781-788. (Pubitemid 351339737)
2. Black DM, Cummings SR, Karpf DB, et al. Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348: 1535-1541. (Pubitemid 26411651)
3. Wells GA, Cranney A, Peterson J, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008:CD001155.
4. MacLean C, Newberry S, Maglione M, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med. 2008; 148:197-213. (Pubitemid 351665507)
5. Kothawala P, Badamgarav E, Ryu S, et al. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc. 2007;82:1493-1501. (Pubitemid 350211697)
6. Cramer JA, Gold DT, Silverman SL, et al. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Os-teoporos Int. 2007;18:1023-1031. (Pubitemid 47019996)
7. Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the fracture intervention trial long-term extension (FLEX): a randomized trial. JAMA. 2006;296: 2927-2938. (Pubitemid 46021497)
8. Lowry KP, Dudley TK, Oddone EZ, et al. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother. 2005; 39:1198-1203. (Pubitemid 40943169)
9. Hyre AD, Krousel-Wood MA, Muntner P, et al. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich). 2007;9:179-186.
10. Burnier M. Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension. Blood Press Monit. 2000;5(suppl 1):S31-S34. (Pubitemid 30428088)
11. Taira DA, Gelber RP, Davis J, et al. Antihypertensive adherence and drug class among Asian Pacific Americans. Ethn Health. 2007;12:265-281. (Pubitemid 46570235)
12. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461. (Pubitemid 34787476)
13. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467. (Pubitemid 34787477)
14. Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005;25:107-130. (Pubitemid 39576680)
15. Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004;15:1003-1008. (Pubitemid 40064656)
16. Siris ES, Harris ST, Rosen CJ, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81:1013-1022. (Pubitemid 44175011)
17. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006;38:922-928. (Pubitemid 44498580)
18. Briesacher BA, Andrade SE, Yood RA, et al. Consequences of poor compliance with bisphosphonates. Bone. 2007;41:882-887. (Pubitemid 47593009)
19. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development of a new method for assessing the cognitive representation about medication. Psychol Health. 1999;14:1-24.
20. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perception and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17: 17-32.
21. Horne R, Cooper V, Gellaitry G, et al. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr. 2007;45:334-341. (Pubitemid 47012382)
22. Lau E, Papaioannou A, Dolovich L, et al. Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008;54:394-402. (Pubitemid 351413664)
23. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psy-chosom Res. 1999;47:555-567. (Pubitemid 30029305)
24. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426. (Pubitemid 46976288)
25. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64:47-54. (Pubitemid 350297308)
26. Horne R, Buick D, Fisher M, et al. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004;15:38-44. (Pubitemid 38096128)
27. Schousboe JT, Dowd BE, Davison ML, et al. Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures. Osteoporos Int. 2010;21:1899-1809.
28. Janz N, Becker M. The health belief model: a decade later. Health Educ Q. 1984;11:1-47.
29. Sheeran P, Abraham C. The health belief model. In: Connor M, Norman P, eds. Predicting Health Behavior. Philadelphia, PA: Open University Press; 1995:23-61.
30. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000;40:173-185. (Pubitemid 30195758)
31. Heisler M, Cole I, Weir D, et al. Does physician communication influence older patients' diabetes self-management and glycemic control? Results from the health and retirement study (HRS). J Gerontol A Biol Sci Med Sci. 2007;62:1435-1442. (Pubitemid 351158373)
32. Wroth TH, Pathman DE. Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med. 2006;19:478-486. (Pubitemid 44577206)
33. Piette JD, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med. 2005;165:1749-1755. (Pubitemid 41138963)
34. Thom DH, Bloch DA, Segal ES; Stanford Trust Study Physician Group. An intervention to increase patients' trust in their physicians. Acad Med. 1999;74:195-198. (Pubitemid 29100761)
35. Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49:651-661. (Pubitemid 29314682)
36. Fraenkel L, McGraw S. Participation in medical decision making: the patients' perspective. Med Decis Making. 2007;27:533-538. (Pubitemid 47547600)
37. Unson CG, Siccion E, Gaztambide J, et al. Nonadherence and osteoporosis treatment preferences of older women: a qualitative study. J Wom-ens Health (Larchmt). 2003;12:1037-1045. (Pubitemid 38072422)
38. Ringe JD, Christodoulakos GE, Mellstrom D, et al. Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women. Curr Med Res Opin. 2007;23:2677-2687. (Pubitemid 350146406)
39. Gerend MA, Aiken LS, West SG, et al. Beyond medical risk: investigating the psychological factors underlying women's perceptions of susceptibility to breast cancer, heart disease, and osteoporosis. Health Psychol. 2004;23:247-258. (Pubitemid 38542356)
40. Anderson LA, Dedrick RF. Development of the Trust in Physician Scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67:1091-1100.
41. Thom DH, Ribisl KM, Stewart AL, et al. The Stanford Trust Study Physicians. Further validation and reliability testing of the Trust in Physician Scale. Med Care. 1999;37:510-517.
42. Heisler M, Bouknight RR, Hayward RA, et al. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med. 2002; 17:243-252. (Pubitemid 34415682)
43. Usherwood T, Jones N; Hanover Project Team. Self-perceived health status of hostel residents: use of the SF-36D health survey questionnaire. J Public Health Med. 1993;15:311-314. (Pubitemid 24031308)
44. Black DM, Arden NK, Palermo L, et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14:821-828. (Pubitemid 29210609)
45. Melton LJ III, Atkinson EJ, Cooper C, et al. Vertebral fractures predict subsequent fractures. Osteoporos Int. 1999;10:214-221. (Pubitemid 29458716)
46. Cooper C, Atkinson EJ, O'Fallon WM, et al. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7:221-227.
47. Fink HA, Milavetz DL, Palermo L, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. 2005;20:1216-1222. (Pubitemid 40863810)
48. Kline RB. Principles and Practice of Structural Equation Modeling. New York, NY: The Guilford Press; 2005.
49. Brown C, Battista DR, Bruehlman R, et al. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care. 2005;43:1203-1207. (Pubitemid 43012177)
50. Siris ES, Genant HK, Laster AJ, et al. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18:761-770. (Pubitemid 46684783)
51. Schousboe JT, Vokes T, Broy SB, et al. Vertebral fracture assessment: the 2007 ISCD official positions. J Clin Densitom. 2008;11:92-108. (Pubitemid 351602190)
52. Genant HK, Li J, Wu CY, et al. Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom. 2000;3:281-290.
53. Schousboe JT, Fink HA, Lui LY, et al. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture. J Bone Miner Res. 2006;21:1557-1564. (Pubitemid 44484600)
54. Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76-87. (Pubitemid 350294021)
55. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165:1147-1152. (Pubitemid 40720739)
56. Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol. 2000;35(suppl 3):S23-S26.
57. Beach MC, Sugarman J, Johnson RL, et al. Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med. 2005;3:331-338. (Pubitemid 41176309)
58. Ellis JJ, Erickson SR, Stevenson JG, et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638-645.
59. Murphy DA, Sarr M, Durako SJ, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 2003;157:249-255. (Pubitemid 36343379)
60. McHorney CA, Schousboe JT, Cline RR, et al. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates. Curr Med Res Opin. 2007;23:3137-3152.